Retinoblastoma MRI: Difference between revisions

Jump to navigation Jump to search
m (Bot: Removing from Primary care)
 
(25 intermediate revisions by 4 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Retinoblastoma}}
{{Retinoblastoma}}
{{CMG}}{{AE}}{{Simrat}}
{{CMG}}; {{AE}} {{Sahar}} {{Simrat}}
==Overview==
==Overview==
On [[head]] and [[neck]] [[MRI]], retinoblastoma is characterized by isointense to hypointense mass on T1-weighted MRI and hyperintense mass on T2-weighted MRI.<ref name="radio">  Retinoblastoma. Radiopedia(2015) http://radiopaedia.org/articles/retinoblastoma Accessed on October 10 2015</ref>
[[Magnetic resonance imaging|MRI]] findings of retinoblastoma include hyperintense [[mass]] on T1-weighted [[MRI]] and hypointense [[mass]] on T2-weighted [[MRI]].
 
==MRI==
==MRI==
[[MRI]] is the modality of choice for pre-treatment staging on retinoblastoma.
*[[Magnetic resonance imaging|MRI imaging study]] of retinoblastoma was first introduced in1980.<ref name="Schueler2003">{{cite journal|last1=Schueler|first1=A O|title=High resolution magnetic resonance imaging of retinoblastoma|journal=British Journal of Ophthalmology|volume=87|issue=3|year=2003|pages=330–335|issn=00071161|doi=10.1136/bjo.87.3.330}}</ref>
*The MRI features of retinoblastoma include:<ref name="radio"> Retinoblastoma. Radiopedia(2015) http://radiopaedia.org/articles/retinoblastoma Accessed on October 10 2015</ref>
*[[MRI]] is [[Accuracy|accurate]] for [[tumor]] [[Cancer staging|staging]] and evaluation of [[metastatic]] [[risk factors]].<ref name="de GraafBarkhof2005">{{cite journal|last1=de Graaf|first1=Pim|last2=Barkhof|first2=Frederik|last3=Moll|first3=Annette C.|last4=Imhof|first4=Saskia M.|last5=Knol|first5=Dirk L.|last6=van der Valk|first6=Paul|last7=Castelijns|first7=Jonas A.|title=Retinoblastoma: MR Imaging Parameters in Detection of Tumor Extent|journal=Radiology|volume=235|issue=1|year=2005|pages=197–207|issn=0033-8419|doi=10.1148/radiol.2351031301}}</ref>
{| style="border: 0px; font-size: 90%; margin: 3px; width: 600px" align=center
*It is also used as an additional [[diagnostic]] tool in suspected retinoblastoma cases.<ref name="pmid22988349">{{cite journal |vauthors=Meel R, Radhakrishnan V, Bakhshi S |title=Current therapy and recent advances in the management of retinoblastoma |journal=Indian J Med Paediatr Oncol |volume=33 |issue=2 |pages=80–8 |date=April 2012 |pmid=22988349 |pmc=3439795 |doi=10.4103/0971-5851.99731 |url=}}</ref>
|valign=top|
*[[MRI|MRI's]] [[Diagnosis|diagnostic]] value in the [[diagnosis]] of advanced retinoblastoma is greater than [[CT scan]].<ref name="de Jongde Graaf2014">{{cite journal|last1=de Jong|first1=Marcus C.|last2=de Graaf|first2=Pim|last3=Noij|first3=Daniel P.|last4=Göricke|first4=Sophia|last5=Maeder|first5=Philippe|last6=Galluzzi|first6=Paolo|last7=Brisse|first7=Hervé J.|last8=Moll|first8=Annette C.|last9=Castelijns|first9=Jonas A.|title=Diagnostic Performance of Magnetic Resonance Imaging and Computed Tomography for Advanced Retinoblastoma|journal=Ophthalmology|volume=121|issue=5|year=2014|pages=1109–1118|issn=01616420|doi=10.1016/j.ophtha.2013.11.021}}</ref>
|+
*[[MRI]] findings [[diagnostic]] of retinoblastoma are:
! style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF|MRI component}}
**'''On T1 image:''' Hyperintense [[mass]] compared to [[vitreous body]]
! style="background: #4479BA; width: 400px;" | {{fontcolor|#FFF|Features}}
**'''On T2 image:''' Hypointense [[mass]] compared to [[vitreous body]]
*[[Magnetic resonance imaging|MRI]] can differentiate the [[tumor]] with secondary [[retinal detachment]] from other [[causes]] of subretinal effusion or [[Retinal detachment|detachment]], such as [[Coats disease|Coats' disease]], primary hyperplastic [[vitreous]], and [[retinopathy of prematurity]].
*Also, some experts argue that [[CT-scans|CT imaging studies]] in [[bilateral]] retinoblastoma will increase the risk of future [[malignancies]]. [[MRI]] is not associated with such risk.
*[[MRI]] is also the study of choice to rule out extra-[[ocular]] extension of the [[tumor]].<ref name="pmid22988349">{{cite journal |vauthors=Meel R, Radhakrishnan V, Bakhshi S |title=Current therapy and recent advances in the management of retinoblastoma |journal=Indian J Med Paediatr Oncol |volume=33 |issue=2 |pages=80–8 |date=April 2012 |pmid=22988349 |doi=10.4103/0971-5851.99731 |url=}}</ref>
{|
|[[image:Retinoblastoma-edited.jpg|thumb|400px|T2 image, Case courtesy of Dr Jeremy Jones, Radiopaedia.org, rID: 22114]]
<br style="clear:left" />
|-
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |
|}
:T1
{|
| style="padding: 5px 5px; background: #F5F5F5;" |
|[[image:Retinoblastoma-5 edited.jpg|thumb|400px|T1 image, Case courtesy of Dr Jeremy Jones, Radiopaedia.org, rID: 22114]]
*intermediate signal intensity, hyperintense c.f. vitreous
<br style="clear:left" />
|-
| style="padding: 5px 5px; background: #DCDCDC;font-weight: bold" |
:T2
| style="padding: 5px 5px; background: #F5F5F5;" |
*hypointense c.f. vitreous
|-
| style="padding: 5px 5px; background: #DCDCDC;font-weight: bold" |
:T1 C+ (Gd)
| style="padding: 5px 5px; background: #F5F5F5;" |
*The mass usually enhances relatively homogeneously when small
*Larger tumours often have areas of necrosis, rendering it heterogeneous
*Linear enhancement of the choroid beyond the margins of the tumour should raise the possibility of choroidal involvement, although inflammation may lead to similar appearance
*Enhancement of the anterior chamber need not represent tumour involvement, with hyperaemia, uveitis and iris neovascularisation all leading to asymmetric enhancement
*Careful assessment of the optic disc and optic nerve should be carried out to assess for involvement
*Extra-ocular extension through the sclera will be visible as interruption of the otherwise hypointense non-enhancing sclera by enhancing tumour
|-
| style="padding: 5px 5px; background: #DCDCDC;font-weight: bold" |
:DWI
| style="padding: 5px 5px; background: #F5F5F5;" |
*The tumour shows restricted diffusion on DWI at high b values. It exhibits low ADC values in contrast to the high intensity of the vitreous in the ADC maps
*ADC map can be used to differentiate viable and necrotic tumour
*DWI is valuable in evaluating the response to eye-preservation treatment
|-
|-
|}
|}
[[File:Axial MRI scan.jpg|thumb|none|200px|Axial MRI showing retinoblastoma<ref name="radio1">Image courtesy of Radswiki [http://www.radiopaedia.org Radiopaedia] (original file [http://radiopaedia.org/cases/retinoblastoma-3]).[http://radiopaedia.org/licence Creative Commons BY-SA-NC</ref>]]
[[File:T1 MRI of retinoblastoma.jpg|thumb|none|200px|T1 MRI showing retinoblastoma<ref name="radio1">Image courtesy of Dr. Vinay Shah [http://www.radiopaedia.org Radiopaedia] (original file [http://radiopaedia.org/cases/retinoblastoma-9]).[http://radiopaedia.org/licence Creative Commons BY-SA-NC</ref>]]
[[File:T2 MRI of retinoblastoma.jpg|thumb|none|200px|T2 MRI showing retinoblastoma<ref name="radio1">Image courtesy of Dr. Vinay Shah [http://www.radiopaedia.org Radiopaedia] (original file [http://radiopaedia.org/cases/retinoblastoma-9]).[http://radiopaedia.org/licence Creative Commons BY-SA-NC</ref>]]


==References==
==References==
{{reflist|2}}
{{reflist|2}}
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}


[[Category:Disease]]
[[Category:Medicine]]
[[Category:Ophthalmology]]
[[Category:Oncology]]
[[Category:Hereditary cancers]]
[[Category:Up-To-Date]]
[[Category:Surgery]]

Latest revision as of 23:59, 29 July 2020

Retinoblastoma Microchapters

Home

Patient Information

Overview

Historical perspective

Classification

Pathophysiology

Causes

Differentiating Retinoblastoma from other Diseases

Epidemiology & Demographics

Risk Factors

Screening

Natural history, Complications, and Prognosis

Diagnosis

Diagnostic Study of Choice

History & Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Retinoblastoma MRI On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Retinoblastoma MRI

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Retinoblastoma MRI

CDC on Retinoblastoma MRI

Retinoblastoma MRI in the news

Blogs on Retinoblastoma MRI

Directions to Hospitals Treating Retinoblastoma

Risk calculators and risk factors for Retinoblastoma MRI

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sahar Memar Montazerin, M.D.[2] Simrat Sarai, M.D. [3]

Overview

MRI findings of retinoblastoma include hyperintense mass on T1-weighted MRI and hypointense mass on T2-weighted MRI.

MRI

T2 image, Case courtesy of Dr Jeremy Jones, Radiopaedia.org, rID: 22114


T1 image, Case courtesy of Dr Jeremy Jones, Radiopaedia.org, rID: 22114


References

  1. Schueler, A O (2003). "High resolution magnetic resonance imaging of retinoblastoma". British Journal of Ophthalmology. 87 (3): 330–335. doi:10.1136/bjo.87.3.330. ISSN 0007-1161.
  2. de Graaf, Pim; Barkhof, Frederik; Moll, Annette C.; Imhof, Saskia M.; Knol, Dirk L.; van der Valk, Paul; Castelijns, Jonas A. (2005). "Retinoblastoma: MR Imaging Parameters in Detection of Tumor Extent". Radiology. 235 (1): 197–207. doi:10.1148/radiol.2351031301. ISSN 0033-8419.
  3. 3.0 3.1 Meel R, Radhakrishnan V, Bakhshi S (April 2012). "Current therapy and recent advances in the management of retinoblastoma". Indian J Med Paediatr Oncol. 33 (2): 80–8. doi:10.4103/0971-5851.99731. PMC 3439795. PMID 22988349.
  4. de Jong, Marcus C.; de Graaf, Pim; Noij, Daniel P.; Göricke, Sophia; Maeder, Philippe; Galluzzi, Paolo; Brisse, Hervé J.; Moll, Annette C.; Castelijns, Jonas A. (2014). "Diagnostic Performance of Magnetic Resonance Imaging and Computed Tomography for Advanced Retinoblastoma". Ophthalmology. 121 (5): 1109–1118. doi:10.1016/j.ophtha.2013.11.021. ISSN 0161-6420.